The recently released White House Office of Science and Technology Policy (OSTP) report, Bold Goals for U.S. Biotechnology and Biomanufacturing, highlights where insights provided by human genetics and genomics are fundamental for the health biotechnology ecosystem and are critical components of the bioeconomy. This report comes after OSTP solicited public input in a Request for... Read More
At the ASHG 2022 Annual Meeting, members of the ASHG Professional Practice and Social Implications Committee (PPSI) followed up on the recently published Guidance on addressing underrepresentation in genetics and genomics research through community engagement. Organized by ASHG and PPSI members Kyle Brothers, MD, PhD, Amy Lemke, PhD, MS, and Maya Sabatello, LLB, PhD, the... Read More
The 10th anniversary of the Rally for Medical Research took place on September 14, 2022. ASHG is proud to have again sponsored this event on Capitol Hill, which brought together 250 participants from more than 30 states and Washington, D.C. to meet with 190 congressional offices. Science advocates were enthusiastic to return to the capital... Read More
Posted By: Sara Cullinan, PhD, Deputy Editor, AJHG What prompted you to start working on this project? A critical challenge in genomic medicine is developing insight into the underlying mechanisms that are responsible for association signals detected by genome-wide association studies (GWAS). One of the primary sources of motivation for this project was to harness... Read More
Loren Saulsberry, PhD, Human Genetics Scholar, is an Assistant Professor in Health Policy and Health Services Research in the Department of Public Health Sciences at The University of Chicago. Her research program aims to evaluate and guide the implementation of pharmacogenomics (PGx) into clinical practice in a manner that advances health equity within genomic medicine.... Read More
ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy